LeMaitre Vascular, Inc. · Healthcare · Medical Instruments & Supplies
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
At close
$108.20
+$0.02 (+0.02%) Close
Prev closePrevC$108.18
OpenOpen$108.20
Day highHigh$108.20
Day lowLow$108.20
VolumeVol40
Avg volAvgVol191,476
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$2.45B
P/E ratio
46.84
FY Revenue
$240.87M
EPS
2.31
Gross Margin
70.97%
Sector
Healthcare
AI report sections
BULLISH
LMAT
LeMaitre Vascular, Inc.
LeMaitre Vascular exhibits solid profitability, cash generation, and modest revenue and earnings growth, supported by a strong balance sheet. Technically, the stock is in an extended uptrend with price well above key moving averages and multiple bullish momentum signals, while overbought oscillators and elevated valuation multiples indicate a more stretched positioning. Short interest and news flow point to constructive sentiment with some hedging activity rather than extreme pessimism.
AI summarized at 4:59 PM ET, 2026-03-01
AI summary scores
INTRADAY:63SWING:78LONG:69
Volume vs average
Intraday (cumulative)
+134% (Above avg)
Vol/Avg: 2.34×
RSI
85.98(Overbought)
Overbought (>70)
0255075100
MACD momentum
Intraday
-0.05 (Weak)
MACD: -0.20 Signal: -0.15
Short-Term
+1.67 (Strong)
MACD: 3.48 Signal: 1.81
Long-Term
+1.37 (Strong)
MACD: 3.47 Signal: 2.10
Intraday trend score
93.42
LOW78.42HIGH93.42
Latest news
LMAT•12 articles•Positive: 5Neutral: 3Negative: 0
PositiveGlobeNewswire Inc.• Na
LeMaitre to Participate at Upcoming Investor Conferences in March
LeMaitre Vascular announced its participation in five investor conferences scheduled for March 2026, including presentations at the Leerink Partners Global Healthcare Conference, Citizens Life Sciences Conference, and KeyBanc Capital Markets Healthcare Forum, as well as 1x1 meetings at the Barclays Annual Global Healthcare Conference and ROTH Conference.
The company's active participation in multiple high-profile investor conferences demonstrates management engagement with the investment community and confidence in the business. This level of conference participation typically indicates positive momentum and investor interest in the company's growth prospects.
NeutralGlobeNewswire Inc.• Lemaitre Vascular, Inc.
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025
LeMaitre Vascular will release its third quarter 2025 financial results on November 6, 2025, after market close, with a conference call scheduled for 5:00 PM EST to discuss results and company outlook.
Standard financial reporting announcement with no explicit positive or negative indicators, simply providing routine investor communication about upcoming quarterly results
PositiveThe Motley Fool• Jesterai
LeMaitre (LMAT) Q2 Revenue Jumps 15%
LeMaitre Vascular reported strong Q2 2025 financial results, with GAAP revenue of $64.2 million, exceeding estimates and growing 15% year-over-year. The company saw significant growth in catheters and grafts, expanded gross margins to 70%, and raised full-year guidance.
Exceeded earnings estimates, achieved 15% revenue growth, expanded gross margins, raised full-year guidance, strong performance in international markets, and increased quarterly dividend by 25%
NeutralGlobeNewswire Inc.• Anteris Technologies Global Corp.
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
Anteris Technologies Global Corp. announced the appointments of David Roberts and Gregory Moss to its Board of Directors, as the company transitions to its next phase of growth with the upcoming global pivotal PARADIGM study for its DurAVR® Transcatheter Heart Valve.
AVRLMATAnteris TechnologiesDurAVR® Transcatheter Heart ValvePARADIGM studyBoard of Directors
Sentiment note
The article mentions that David Roberts, the President of LeMaitre Vascular, has been appointed to Anteris' Board of Directors. This information is provided in the context of Anteris' leadership changes, without any specific commentary on LeMaitre Vascular.
LeMaitre Vascular, Inc. announced its intention to offer $150 million aggregate principal amount of Convertible Senior Notes due 2030 in a private offering. The company plans to use the net proceeds for working capital and general purposes, including potential acquisitions.
The company is raising funds through a convertible notes offering, which suggests it has growth plans and is seeking to expand its business, which is a positive sign.
PositiveGlobeNewswire Inc.• N/A
LeMaitre to Participate at Upcoming Investor Conferences in November
LeMaitre Vascular, a provider of devices for peripheral vascular disease, announced that its President, David Roberts, will present at three upcoming investor conferences in November 2024.
The article highlights that LeMaitre Vascular, a provider of devices for peripheral vascular disease, will be participating in three upcoming investor conferences, which suggests the company is actively engaging with the investment community and is likely in a good position to showcase its products and growth prospects.
PositiveGlobeNewswire Inc.• N/A
LeMaitre to Participate at Upcoming Investor Conferences in September
LeMaitre Vascular, a provider of devices for peripheral vascular disease, announced that its management will be participating in three upcoming investor conferences in September.
The article highlights LeMaitre Vascular's participation in upcoming investor conferences, which suggests the company is actively engaging with the investment community and is likely in a good financial position to do so.
NeutralGlobeNewswire Inc.• N/A
LeMaitre Will Announce Second Quarter 2024 Earnings Results August 1, 2024 - GlobeNewswire
LeMaitre Vascular, Inc. announced that it will release its second quarter 2024 financial results on August 1, 2024, and host a conference call to discuss the results, business highlights, and company outlook.
The article provides factual information about the company's upcoming financial results release and conference call, without any explicit positive or negative sentiment.
UnknownZacks Investment Research• Zacks Equity Research
Merit Medical (MMSI) Hits 52-Week High: What's Aiding It?
Investors are optimistic about Merit Medical's (MMSI) strong product portfolio.
ECLDVAMMSILMAT
UnknownZacks Investment Research• Zacks Equity Research
Glaukos (GKOS) Reaches 52-Week High: What's Driving the Stock?
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.
ECLDVALMATGKOS
UnknownZacks Investment Research• Zacks Equity Research
Investors are optimistic about Intuitive Surgical's (ISRG) strength in robotics.
ECLISRGDVALMAT
UnknownZacks Investment Research• Zacks Equity Research
Encompass Health (EHC) Expands in Louisville With New Rehab Unit
Encompass Health (EHC) and Baptist Health inaugurate a 40-bed inpatient rehabilitation hospital in Louisville, enhancing regional care and expanding EHC's network to 163 facilities.
THCLMATEHCBVS
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal
